Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Technical University Of Munich maintains a company patent portfolio within the Biotechnology & Pharmaceuticals technology area. Currently, the portfolio features 1 pending office action. This specific volume of activity indicates the current scale of the university's engagement with the patent office in this technical sector.
The prosecution is handled by 1 distinct examiner and is located within 1 distinct art unit. Having a single point of contact in the patent office means that the university's current filings are subject to a very specific set of examination criteria. The use of 1 distinct art unit suggests that the subject matter is highly specialized within the broader Biotechnology & Pharmaceuticals field.
MARTIN, KEVIN STEPHEN is the busiest examiner for this portfolio, overseeing 1 busiest examiner pending office action. Since this individual is responsible for the only pending action, the immediate prosecution results for Technical University Of Munich are tied to this single examiner's review. Practitioners should focus on the specific requirements of MARTIN, KEVIN STEPHEN to move this 1 pending office action toward a final resolution.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MARTIN, KEVIN STEPHEN | 1 | 77.4% | +23.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18836290 | COMPOUNDS FOR LABELLING NUCLEIC ACID AND USES THEREOF | MARTIN, KEVIN STEPHEN | — |
| Art Unit | Apps |
|---|---|
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18836290 | COMPOUNDS FOR LABELLING NUCLEIC ACID AND USES THEREOF | MARTIN, KEVIN STEPHEN | 1624 | §112 | Non-Final OA | — | Pending | Aug 06, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTechnical University Of Munich has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Kevin Stephen Martin has the most, with 1 of Technical University Of Munich's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
